Invention Grant
- Patent Title: Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
-
Application No.: US15514739Application Date: 2015-09-29
-
Publication No.: US10793572B2Publication Date: 2020-10-06
- Inventor: John Michael Southern , Stephen J. Connon
- Applicant: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN
- Applicant Address: IE Dublin
- Assignee: THE PROVOST FELLOWS FOUNDATION SCHOLARS AND THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH
- Current Assignee: THE PROVOST FELLOWS FOUNDATION SCHOLARS AND THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH
- Current Assignee Address: IE Dublin
- Agency: Hoffman Warnick LLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@55edbb4b
- International Application: PCT/EP2015/072486 WO 20150929
- International Announcement: WO2016/050804 WO 20160407
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519
Abstract:
Disclosed are novel compounds useful in the treatment of multiple sclerosis and other autoimmune diseases. The present invention describes compounds of formula (I) wherein: R1 is selected from H and CH3 R2 is selected from H, C4H9 alkyl, C6H13 alkyl and C3H6-phenyl, said phenyl optionally substituted by OH or OCH3, (1R,2S,5S)-5-methylcyclopent-3-ene-1,2-diol X is O or S Y is C, N or S.
Public/Granted literature
- US20170240553A1 SUBSTITUTED PYRIMIDINE DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE DISEASES Public/Granted day:2017-08-24
Information query
